Literature DB >> 12631923

Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996.

G Goncalves1, A De Araujo, M.L. Monteiro Cardoso.   

Abstract

Vaccination against mumps in Portugal began in 1987, with the introduction of the combined measles, mumps, and rubella vaccine (MMR) in the national vaccination programme (Programa Nacional de Vacinacao: PNV) for both sexes at 15 months. In November 1990,

Entities:  

Year:  1998        PMID： 12631923     DOI： 10.2807/esm.03.12.00101-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  9 in total

1.  Comparison between indirect immunofluorescence assay and shell vial culture for detection of mumps virus from clinical samples.

Authors:  Jordi Reina; Francisca Ballesteros; Enrique Ruiz de Gopegui; Maria Munar; Margarita Mari
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  [Mumps in a urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures].

Authors:  R de los Ríos Martín; N García Marín; J Sanz Moreno; E Ballester Orcal
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

3.  Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.

Authors:  C Amela; I Pachón; F de Ory
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 4.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

6.  Persistence of rubella and mumps antibodies, following changes in the recommended age for the second dose of MMR vaccine in Portugal.

Authors:  G Gonçalves; J Frade; M S J Nascimento; J R Mesquita; C Nunes
Journal:  Epidemiol Infect       Date:  2016-08-04       Impact factor: 4.434

7.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

Review 8.  Resurgence of mumps in Korea.

Authors:  Sun Hee Park
Journal:  Infect Chemother       Date:  2015-03-30

9.  Complete Multilineage CD4 Expression Defect Associated With Warts Due to an Inherited Homozygous CD4 Gene Mutation.

Authors:  Rosa Anita Fernandes; Martin Perez-Andres; Elena Blanco; Maria Jara-Acevedo; Ignacio Criado; Julia Almeida; Vitor Botafogo; Ines Coutinho; Artur Paiva; Jacques J M van Dongen; Alberto Orfao; Emilia Faria
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.